Prostate Cancer - Results from #40

Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment. April 15, 2025

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants. April 15, 2025

An Online Treatment Decision Aid for Men with Low-risk Prostate Cancer Eligible for Active Surveillance and Their Partners Increases the Uptake of Active Surveillance: The Navigate Randomised Controlled Trial. April 15, 2025

External Validation of an Artificial Intelligence Algorithm Using Biparametric MRI and Its Simulated Integration with Conventional PI-RADS for Prostate Cancer Detection. April 15, 2025

Visceral metastases, platelet dynamics, and PSA decline: from biomarkers to better outcomes in [177Lu]Lu‑PSMA‑617 therapy in metastatic castration-resistant prostate cancer. April 14, 2025

Impact of ISUP grade group on cancer-specific mortality in radical prostatectomy-treated prostate cancer patients with organ-confined disease. April 14, 2025

Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robotic Urology Section Scientific Working Group. April 14, 2025

Stage IV Prostate Cancer Presenting With a Low Prostate-Specific Antigen Level: A Case Report. April 14, 2025

Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study. April 14, 2025

A comparison of surgical outcomes between outpatient and inpatient robot-assisted radical prostatectomy: A systematic review and meta-analysis. April 14, 2025

Assessment of a Polygenic Risk Score in Screening for Prostate Cancer. April 14, 2025

Suffering in Silence: Loneliness Among Men with Prostate Cancer and the Potential for Exercise as Connection. April 11, 2025

Characteristic Findings in Aborted Robot-Assisted Radical Prostatectomies. April 11, 2025

A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial. April 11, 2025

Transperineal prostate biopsy without routine antibiotics demonstrates decreased infection risk. April 11, 2025

Correlation of T2-Weighted Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Cone Beam Computed Tomography (CBCT) Radiomic Features for Prostate Cancer. April 11, 2025

Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort. April 10, 2025

Pelvic Lymph Node Dissection in Prostate Cancer: Evidence and Implications. April 10, 2025

Making prostate cancer research accessible: chatGPT-4 as a tool to enhance lay communication. April 10, 2025

Validation and Derivation of MicroRNA-based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer. April 10, 2025

Page 3 of 1473